Page last updated: 2024-10-24

chloroquine and Hypoxia-Ischemia, Brain

chloroquine has been researched along with Hypoxia-Ischemia, Brain in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Hypoxia-Ischemia, Brain: A disorder characterized by a reduction of oxygen in the blood combined with reduced blood flow (ISCHEMIA) to the brain from a localized obstruction of a cerebral artery or from systemic hypoperfusion. Prolonged hypoxia-ischemia is associated with ISCHEMIC ATTACK, TRANSIENT; BRAIN INFARCTION; BRAIN EDEMA; COMA; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, P1
Hao, L1
Guo, YY1
Yang, GL1
Mei, H1
Li, XH1
Zhai, QX1

Other Studies

1 other study available for chloroquine and Hypoxia-Ischemia, Brain

ArticleYear
Chloroquine inhibits autophagy and deteriorates the mitochondrial dysfunction and apoptosis in hypoxic rat neurons.
    Life sciences, 2018, Jun-01, Volume: 202

    Topics: Animals; Apoptosis; Atrophy; Autophagy; Cell Hypoxia; Chloroquine; Hypoxia-Ischemia, Brain; Membrane

2018